We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
-10.24%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$3.03B
AUM Growth
-$37.2M
Cap. Flow
+$105M
Cap. Flow %
3.46%
Top 10 Hldgs %
57.55%
Holding
43
New
5
Increased
14
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$102M
2
MDT icon
Medtronic
MDT
+$75.3M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$45.2M
4
GMED icon
Globus Medical
GMED
+$40.5M
5
THC icon
Tenet Healthcare
THC
+$33.6M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$66.6M
2
WBA
Walgreens Boots Alliance
WBA
+$61.2M
3
QTRX icon
Quanterix
QTRX
+$53.2M
4
GSK icon
GSK
GSK
+$44.4M
5
CNC icon
Centene
CNC
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 88.25%
2 Miscellaneous 8.7%
3 Consumer Staples 2.31%
4 Consumer Discretionary 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKIN icon
26
SkinHealth Systems
SKIN
$87.8M
$30.1M 0.99%
5,000,000
+3,250,000
+186% +$22.8M
BMRN icon
27
BioMarin Pharmaceuticals
BMRN
$12.5B
$26.5M 0.87%
+300,000
New +$26.7M
OSUR icon
28
OraSure Technologies
OSUR
$239M
$25.2M 0.83%
4,250,000
– –
QDEL icon
29
QuidelOrtho
QDEL
$729M
$23.7M 0.78%
+325,000
New +$26M
COLL icon
30
Collegium Pharmaceutical
COLL
$711M
$23.5M 0.77%
1,050,000
– –
PTON icon
31
Peloton Interactive
PTON
$2.13B
$22.7M 0.75%
4,500,000
+1,500,000
+50% +$10.7M
QGEN icon
32
Qiagen
QGEN
$8.77B
$16.2M 0.53%
+377,222
New +$17.6M
BKDT
33
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
$15.1M 0.5%
250,000
– –
CVAC
34
DELISTED
CureVac
CVAC
$12M 0.39%
1,750,000
+287,500
+20% +$2.54M
PBYI icon
35
Puma Biotechnology
PBYI
$477M
$11.1M 0.37%
4,235,000
– –
INGN icon
36
Inogen
INGN
$138M
$10.4M 0.34%
2,000,000
+850,000
+74% +$6.04M
BCYC
37
Bicycle Therapeutics
BCYC
$257M
$8.04M 0.26%
+400,000
New +$9.15M
EXEL icon
38
Exelixis
EXEL
$14.1B
$6.55M 0.22%
300,000
-1,250,000
-81% -$26.1M
SLDB icon
39
Solid Biosciences
SLDB
$897M
$3.57M 0.12%
1,418,439
– –
CANO
40
DELISTED
Cano Health, Inc.
CANO
$1.01M 0.03%
40,000
– –
CNC icon
41
Centene
CNC
$33.4B
– –
-400,000
Closed -$27M
DVAX
42
DELISTED
Dynavax Technologies
DVAX
– –
-300,000
Closed -$3.88M
GKOS icon
43
Glaukos
GKOS
$10.1B
– –
-160,000
Closed -$11.4M
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Camber Capital Management held 43 positions worth $3.03B, down 1.2% from $3.07B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Camber Capital Management deployed $105M of net new capital in Q3 2023, opening 5 new positions and adding to 14 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 300,000 shares worth $26.5M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 97% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was Sanofi, an estimated $66.6M trimmed.

  • Camber Capital Management's largest Q3 2023 buy was BioMarin Pharmaceuticals: 300,000 shares worth $26.5M.
  • Camber Capital Management added most to Zimmer Biomet in Q3 2023, an estimated $102M increase.
  • Camber Capital Management's biggest Q3 2023 reduction was Sanofi, cutting an estimated $66.6M.
  • Camber Capital Management fully exited Centene in Q3 2023, selling an estimated $27M.
  • Camber Capital Management's ten largest holdings make up 58% of its $3.03B portfolio in Q3 2023.
  • Camber Capital Management opened 5 new positions and closed 3 in Q3 2023.
  • Camber Capital Management's portfolio value fell 1.2% quarter-over-quarter to $3.03B.

Based on Camber Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.